Healthcare provider profile · identity verified

Mark Capkin, MD

Internal Medicine · PHILADELPHIA, PA · NPI 1114994258

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	635	173
Atorvastatin Calcium	Atorvastatin Calcium	623	184
Gabapentin	Gabapentin	310	71
Losartan Potassium	Losartan Potassium	291	78
Albuterol Sulfate Hfa	Albuterol Sulfate	290	63
Hydrochlorothiazide	Hydrochlorothiazide	276	74
Pantoprazole Sodium	Pantoprazole Sodium	267	69
Lisinopril	Lisinopril	260	68
Metformin Hcl	Metformin Hcl	257	73
Nifedipine Er	Nifedipine	234	54
Omeprazole	Omeprazole	218	54
Montelukast Sodium	Montelukast Sodium	170	37
Furosemide	Furosemide	165	44
Metoprolol Succinate	Metoprolol Succinate	161	43
Levothyroxine Sodium	Levothyroxine Sodium	158	41
Fluticasone Propionate	Fluticasone Propionate	157	40
Metoprolol Tartrate	Metoprolol Tartrate	148	35
Eliquis	Apixaban	147	29
Carvedilol	Carvedilol	136	36
Potassium Chloride	Potassium Chloride	136	37
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	117	17
Clopidogrel	Clopidogrel Bisulfate	100	28
Pravastatin Sodium	Pravastatin Sodium	100	26
Warfarin Sodium	Warfarin Sodium	92	17
Rosuvastatin Calcium	Rosuvastatin Calcium	89	25
Simvastatin	Simvastatin	86	23
Famotidine	Famotidine	78	19
Tamsulosin Hcl	Tamsulosin Hcl	78	32
Hydralazine Hcl	Hydralazine Hcl	75	20
Ezetimibe	Ezetimibe	74	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	71	23
Trazodone Hcl	Trazodone Hcl	70	16
Baclofen	Baclofen	69	suppressed
Trulicity	Dulaglutide	67	12
Spironolactone	Spironolactone	64	19
Pregabalin	Pregabalin	60	suppressed
Glipizide Er	Glipizide	59	13
Escitalopram Oxalate	Escitalopram Oxalate	58	12
Atenolol	Atenolol	54	11
Novolog Flexpen	Insulin Aspart	53	13
Tramadol Hcl	Tramadol Hcl	53	12
Ibuprofen	Ibuprofen	50	16
Oxycodone Hcl	Oxycodone Hcl	50	suppressed
Ketoconazole	Ketoconazole	47	suppressed
Levetiracetam	Levetiracetam	47	suppressed
Prednisone	Prednisone	47	18
Sertraline Hcl	Sertraline Hcl	47	suppressed
Allopurinol	Allopurinol	46	14
Lorazepam	Lorazepam	46	suppressed
Risperidone	Risperidone	46	suppressed
Diclofenac Sodium	Diclofenac Sodium	45	19
Alendronate Sodium	Alendronate Sodium	44	suppressed
Alprazolam	Alprazolam	44	13
Duloxetine Hcl	Duloxetine Hcl	44	suppressed
Januvia	Sitagliptin Phosphate	44	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	12
Xarelto	Rivaroxaban	42	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	12
Synthroid	Levothyroxine Sodium	40	suppressed
Endocet	Oxycodone Hcl/Acetaminophen	39	suppressed
Jardiance	Empagliflozin	38	suppressed
Bumetanide	Bumetanide	37	12
Betamethasone Dipropionate	Betamethasone Dipropionate	36	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	suppressed
Clonazepam	Clonazepam	35	suppressed
Naproxen	Naproxen	35	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	33	suppressed
Lansoprazole	Lansoprazole	32	suppressed
Meloxicam	Meloxicam	32	suppressed
Meclizine Hcl	Meclizine Hcl	31	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	30	11
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Valsartan	Valsartan	28	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Lovastatin	Lovastatin	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Colchicine	Colchicine	25	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	25	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Ozempic	Semaglutide	24	suppressed
Tradjenta	Linagliptin	24	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Glipizide	Glipizide	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	21	suppressed
Clotrimazole	Clotrimazole	20	suppressed
Latanoprost	Latanoprost	20	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	20	suppressed
Ammonium Lactate	Ammonium Lactate	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Amoxicillin	Amoxicillin	18	13
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Finasteride	Finasteride	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Azithromycin	Azithromycin	13	12
Entresto	Sacubitril/Valsartan	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Modafinil	Modafinil	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Letrozole	Letrozole	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error